Exploring the role of EMT in ovarian cancer progression using a multiscale mathematical model
- PMID: 40246908
- PMCID: PMC12006308
- DOI: 10.1038/s41540-025-00508-y
Exploring the role of EMT in ovarian cancer progression using a multiscale mathematical model
Abstract
Epithelial-to-mesenchymal transition (EMT) plays a key role in the progression of cancer tumours, significantly reducing the success of treatment. EMT occurs when a cell undergoes phenotypical changes, resulting in enhanced drug resistance, higher cell plasticity, and increased metastatic abilities. Here, we employ a 3D agent-based multiscale modelling framework using PhysiCell to explore the role of EMT over time in two cell lines, OVCAR-3 and SKOV-3. This approach allows us to investigate the spatiotemporal progression of ovarian cancer and the impacts of the conditions in the microenvironment. OVCAR-3 and SKOV-3 cell lines possess highly contrasting tumour layouts, allowing a wide range of different tumour dynamics and morphologies to be tested and studied. Along with performing sensitivity analysis on the model, simulation results capture the biological observations and trends seen in tumour growth and development, thus helping to obtain further insights into OVCAR-3 and SKOV-3 cell line dynamics.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: Authors S.O., M.W., and D.G. declare no financial or non-financial competing interests. Author M.K.J. serves as Editor-in-Chief of this journal and had no role in the peer-review or decision to publish this manuscript. Author G.P. serves as an Editorial Board Member of this journal and had no role in the peer-review or decision to publish this manuscript. Authors M.K.J. and G.P. declare no financial competing interests.
Figures



















Similar articles
-
Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.J Transl Med. 2022 Dec 3;20(1):556. doi: 10.1186/s12967-022-03776-y. J Transl Med. 2022. PMID: 36463238 Free PMC article.
-
Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.Int J Oncol. 2015 Jan;46(1):272-80. doi: 10.3892/ijo.2014.2695. Epub 2014 Oct 7. Int J Oncol. 2015. PMID: 25310727
-
Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition.Int J Oncol. 2015 Oct;47(4):1451-9. doi: 10.3892/ijo.2015.3122. Epub 2015 Aug 13. Int J Oncol. 2015. PMID: 26316317
-
Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention.Phys Biol. 2019 May 7;16(4):041004. doi: 10.1088/1478-3975/ab157a. Phys Biol. 2019. PMID: 30939460 Review.
-
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression.Int J Mol Sci. 2024 Aug 17;25(16):8972. doi: 10.3390/ijms25168972. Int J Mol Sci. 2024. PMID: 39201656 Free PMC article. Review.
References
-
- Tiwari, N., Gheldof, A., Tatari, M. & Christofori, G. Emt as the ultimate survival mechanism of cancer cells. In Seminars in cancer biology, vol. 22, 194–207 (Elsevier, 2012). - PubMed
-
- Lambert, A. W. & Weinberg, R. A. Linking emt programmes to normal and neoplastic epithelial stem cells. Nat. Rev. Cancer21, 325–338 (2021). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical